Q-Cells announces changes in Supervisory Board composition

Tuesday, 12. May 2009 07:00
Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------




- Menno Harms and Andrew Lee to join Supervisory Board under new
chairman Marcel Brenninkmeijer
- After ten successful years, co-founder Dr. Thomas van Aubel and Dr.
Dinnies von der Osten do not seek reelection

Bitterfeld-Wolfen, 12 May 2009 - The Annual General Meeting of
Q-Cells SE (QCE; ISIN DE0005558662) will elect a new Supervisory
Board on 18 June 2009 due to last year's change of the Company's
legal form into a European Company (SE). The present Chairman of the
Supervisory Board, Dr. Thomas van Aubel, as well as the Vice
Chairman, Dr. Dinnies J. von der Osten, will not stand for reelection
to the Supervisory Board. Both are planning to dedicate themselves
more strongly to their other investments in the future. The
Supervisory Board intends to elect its long-standing member Marcel
Brenninkmeijer, President of the Supervisory Board of Good Energies
AG, as the new Chairman of the Supervisory Board. In addition to
that, two experienced industry experts shall join Q-Cells'
Supervisory Board, namely Prof. Menno Harms, who for many years led
the German business of Hewlett Packard, and Andrew Lee, active in
project financing at Good Energies. Together with Marcel
Brenninkmeijer and Richard Kauffman he will therefore be the third
member of the Q-Cells Supervisory Board nominated by Good Energies.

The supervisory board changes reflect a desire by the Company and
Good Energies to more closely work together to better achieve its
international growth targets amid the current market environment
which is challenging all players in the industry. Good Energies as a
long term investor will thus further extend its personal commitment
to Q-Cells. Good Energies has partnered with management since its
initial investment in 2002.

Dr. Thomas van Aubel and Dr. Dinnies J. von der Osten have
accompanied Q-Cells since the foundation in 1999 both as investors
and Venture Capital investors respectively from day one and as
members of the Supervisory Board. During their incumbency they have
led the Company from a start-up with four employees in the village of
Thalheim via the IPO and the listing in the German technology index
TecDAX to being the world's largest producer of solar cells with
currently more than 2,500 staff worldwide. Q-Cells highly appreciates
their achievements for the Company and thanks both for their
outstanding commitment as well as for the successful and trustful
cooperation over the last ten years.

Contact information:
Q-Cells SE
OT Thalheim
Sonnenallee 17 - 21
06766 Bitterfeld-Wolfen
Germany

Investor Relations:
Stefan Lissner
Phone: +49 - (0)3494 - 6699 10101
investor@q-cells.com

Public Relations:
Stefan Dietrich
Phone: +49 - (0)3494 - 6699 10111
presse@q-cells.com



--- End of Message ---

Q-Cells SE
OT Thalheim, Guardianstr. 16 Bitterfeld-Wolfen
Germany

WKN: 555866; ISIN: DE0005558662; Index: CDAX, GEX, Prime All Share,
TecDAX;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in
Bayerische Börse München,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Börse Stuttgart,
Regulierter Markt in Frankfurter Wertpapierbörse;
Related Links: Global PVQ SE
Author:
Hugin
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.